Company Filing History:
Years Active: 2018-2022
Title: Innovations by Patrick C Falahee in Hematopoietic Stem Cell Mobilization
Introduction
Patrick C Falahee is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of hematopoietic stem cell mobilization, holding two patents that focus on innovative dosing regimens and methods for mobilizing stem and progenitor cells.
Latest Patents
Falahee's latest patents include "Dosing regimens for the mobilization of hematopoietic stem and progenitor cells." This invention provides compositions and methods useful for mobilizing populations of hematopoietic stem and progenitor cells within a donor. It also determines whether samples of mobilized cells are suitable for release for ex vivo expansion and/or therapeutic use. The mobilized hematopoietic stem and progenitor cells can be administered to patients for treating various stem cell disorders, including hematopoietic diseases, metabolic disorders, cancers, and autoimmune diseases. In certain embodiments, the compositions lead to the mobilization of CD34 cells that have immunosuppressive effects, potentially reducing the incidence of graft vs. host disease. Another patent, "Dosing regimens for the mobilization of hematopoietic stem cells," describes similar compositions and methods for mobilizing these vital cells.
Career Highlights
Patrick C Falahee is currently associated with Magenta Therapeutics, Inc., where he continues to advance research in the field of stem cell therapies. His work is pivotal in developing new treatment options for patients suffering from various disorders.
Collaborations
Falahee collaborates with notable colleagues, including Dwight Morrow and Anthony Boitano, contributing to a dynamic research environment that fosters innovation in stem cell mobilization.
Conclusion
Patrick C Falahee's contributions to the field of hematopoietic stem cell mobilization through his patents and work at Magenta Therapeutics, Inc. highlight his commitment to advancing medical science and improving patient outcomes.